Davis E A, Wang B H, Stagg C A, Baldwin W M, Baumgartner W A, Sanfilippo F, Udelsman R
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Transplantation. 1996 Jan 27;61(2):279-84. doi: 10.1097/00007890-199601270-00020.
The cellular response to a wide variety of stresses results in the synthesis of a family of proteins termed heat shock proteins (HSPs). To determine if acute allograft rejection could induce these proteins in a transplanted graft, we examined the HSP response to acute cardiac allograft rejection and analyzed the effect of immunosuppression upon this response. Donor hearts obtained from either Lewis (LEW) or ACI rats were heterotopically transplanted in recipient LEW rats. There were 4 experimental groups: untreated isografted (LEW to LEW) animals (n = 14), untreated allografted (ACI to LEW) animals (n = 14), cyclosporine-treated (10 mg/kg SQ/day) isografted animals (n = 12), and cyclosporine-treated allografted animals (n = 12). Animals were sacrificed on posttransplantation day 2, 4, or 6 (time of rejection for untreated allografts); n = 4-5 for each time point per group. At these times tissue obtained from the transplanted heart was examined histologically and analyzed for HSP72 by quantitative Northern and Western blots. The level of HSP72 in the untreated allografts progressively increased between 2, 4, and 6 days posttransplantation and was significantly greater than that of the untreated isografts at all time points. The HSP72 response in cyclosporine-treated allografts was significantly reduced at 4 and 6 days posttransplantation compared with the untreated allografts. In contrast, there was no difference in the HSP response in treated versus untreated isografts. Additionally, there was no difference in HSP levels in cyclosporine-treated isografts and allografts. These findings demonstrate that HSP expression in the transplanted heart correlates directly with the evolution of acute allograft rejection, and that immunosuppressive therapy inhibits the HSP response. These studies also raise the possibility of a functional role for HSPs in the allogeneic immune response.
细胞对多种应激的反应会导致一类被称为热休克蛋白(HSPs)的蛋白质的合成。为了确定急性同种异体移植排斥反应是否会在移植的移植物中诱导这些蛋白质,我们研究了热休克蛋白对急性心脏同种异体移植排斥反应的应答,并分析了免疫抑制对此应答的影响。从Lewis(LEW)大鼠或ACI大鼠获取的供体心脏异位移植到受体LEW大鼠体内。有4个实验组:未处理的同基因移植(LEW到LEW)动物(n = 14)、未处理的同种异体移植(ACI到LEW)动物(n = 14)、环孢素处理(10 mg/kg皮下注射/天)的同基因移植动物(n = 12)以及环孢素处理的同种异体移植动物(n = 12)。在移植后第2、4或6天(未处理的同种异体移植的排斥时间)处死动物;每组每个时间点n = 4 - 5。在这些时间点,对从移植心脏获取的组织进行组织学检查,并通过定量Northern印迹和Western印迹分析热休克蛋白72(HSP72)。未处理的同种异体移植中HSP72的水平在移植后2、4和6天逐渐升高,并且在所有时间点均显著高于未处理的同基因移植。与未处理的同种异体移植相比,环孢素处理的同种异体移植在移植后第4天和第6天的HSP72应答显著降低。相比之下,处理过的和未处理的同基因移植的热休克蛋白应答没有差异。此外,环孢素处理的同基因移植和同种异体移植中的热休克蛋白水平没有差异。这些发现表明,移植心脏中的热休克蛋白表达与急性同种异体移植排斥反应的进展直接相关,并且免疫抑制疗法会抑制热休克蛋白应答。这些研究还提出了热休克蛋白在同种异体免疫反应中发挥功能作用的可能性。